Les Ulis, France

Nobumichi-André Sasaki


Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2007-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nobumichi-André Sasaki: Innovator in Amino Acid Research

Introduction

Nobumichi-André Sasaki is a prominent inventor based in Les Ulis, France. He has made significant contributions to the field of amino acid research, holding a total of 2 patents. His work focuses on innovative methods for preparing specific amino acids and their applications in medicine.

Latest Patents

Sasaki's latest patents include a method for preparing (2S, 3R, 4S)-4-hydroxyisoleucine and analogues thereof. This invention concerns a method for preparing α-amino acids of general formula (2S-1), where the group R1 can represent a hydrogen atom, a protecting group for the amino group, or a group of formula —COOR2. Here, R2 can be a C1-C6 alkyl group, an aryl, or an aralkyl group. Additionally, the invention discusses the use of these α-amino acids as medicine. Another notable patent involves the use of biguanide derivatives for creating a medicine with a wound healing effect. This invention relates to biguanide derivatives of a specific general formula.

Career Highlights

Nobumichi-André Sasaki is affiliated with the Centre National de la Recherche Scientifique, a leading research institution in France. His work has been instrumental in advancing the understanding and application of amino acids in various medical fields.

Collaborations

Sasaki has collaborated with notable colleagues, including Pierre Jean-Paul Potier and Maria Conception Achab. Their joint efforts have contributed to the development of innovative solutions in the realm of amino acid research.

Conclusion

Nobumichi-André Sasaki's contributions to amino acid research and his innovative patents highlight his role as a significant inventor in the scientific community. His work continues to influence the field and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…